Cardiogenic Shock - Springer Nature

Comparison of in-hospital outcomes of acute myocardial infarction between patients with cardiogenic shock and with cardiac arrest

However, there were few studies that directly related in-hospital deaths directly between AMI, which was complicated with CS and complicated with CA. The aim of this research was to measure in-hospital outcomes between AMI, CS, and CA, which is more difficult with CA. We also subdivided the CA group into CA with persistent CS and CA without persistent CS. In the CA without a persistent CS group and the CS group, preferable neurological function was more prevalent in the CA without a CS group or the CS group than in the CA with persistent CS group. In conclusion, in-hospital mortality in AMI patients with CA was higher than in those with CS. However, when we divided AMI patients with CA into those with and without persistent CS, AMI patients with persistent CS was the lowest in CA without persistent CS, followed by CS, and the highest in CA with persistent CS.

Source link: https://doi.org/10.1007/s00380-022-02145-5

Impact of time to diagnosis on the occurrence of cardiogenic shock in MIS-C post-COVID-19 infection

Background In children with multisystem inflammatory syndrome, diagnostic delay could be related to severity. Methods A single-center prospective cohort observational study at a tertiary care hospital was conducted between May 2020 and July 2022. The result was remarkably 60 children were approved for inclusion, and 31 were eventually evaluated [52% males, median age 8. 8 years] is reported. According to a study by age, prevalence over the mean, time to diagnosis, high C-reactive protein, and a high N-terminal pro-B-type natriuretic peptide were all related with cardiogenic shock [odds ratio 6. 13, 2. 08, and 1. 70, respectively]. [adjusted OR 21. 2 ] : Time to diagnosis u2265 6 days was associated with cardiogenic shock in multivariable study. The introduction of age > 8 years and NT-proBNP at diagnosis u2265 11,254 ng/L increased the specificity to 91% and a specificity of 77% in predicting cardiogenic shock.

Source link: https://doi.org/10.1007/s12519-022-00681-8

Severe COVID-19-associated myocarditis with cardiogenic shock – management with assist devices – a case report & review

Background Primary viral myocarditis associated with acute respiratory syndrome coronavirus 2 infection is a rare condition. With simultaneous veno-arterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with an Impella, we discuss the case of unvaccinated, healthy patient with cardiogenic shock in the context of a COVID-19-associated myocarditis and therapy with simultaneous veno-arterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with an Impella.

Source link: https://doi.org/10.1186/s12871-022-01890-4

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions